The overall quality of Chinese medicine is uneven, restricting the healthy development of the Chinese medicine industry

At present, the concentration of Chinese medicine industry in China is low, the resources of wild Chinese herbal medicine are seriously damaged, and the quality of some Chinese herbal medicines is declining, which affects the sustainable development of Chinese medicine. It is necessary to build a standardized service support system for Traditional Chinese medicine, and through market cooperation model innovation, to promote the Chinese medicine industry "to plant good medicine, produce good medicine, make good medicine
This is a scene that is often seen in the Chaidamu Basin of Qinghai. "In just a few years, our planting base has grown to nearly 40,000 mu." Wang Shuqin, general manager of Qinghai Deling Harun Jieyu Planting Company, told the Economic Daily that people are now paying more and more attention to health and wellness, and the demand for radon, one of the four treasures of Chinese medicine, is rising.
, in recent years, the demand for Chinese medicine at home and abroad continues to be strong, the rapid development of the Chinese medicine industry. However, the overall quality of Chinese medicine is difficult to say satisfactory, planting and initial processing mode extensive resulting in the effective composition content of medicinal herbs is not up to standard, agricultural residue heavy metal content exceeds the standard and other issues, has become a major bottleneck restricting the healthy development of the Chinese medicine industry. To improve the quality of Chinese medicine products and enhance the core competitiveness of the Chinese medicine industry, it is urgent to standardize the national standards of unity, science and high quality.Quality needs to be improved
Since this year, the Chinese medicine industry policy has been improving, the Outline of the Chinese Medicine Development Strategy Plan (2016-2030) and the Guidance on Promoting the Healthy Development of the Pharmaceutical Industry have been issued one after another, and the top-level design has gradually become clear, the target tasks have been constantly focused, and safeguards have been strengthened.
12th Five-Year Plan period, the pharmaceutical industry maintained a sustained growth momentum, with the total output value of the pharmaceutical industry reaching 268.85 billion yuan in 2015, of which the total output value of Chinese medicine reached 786.7 billion yuan. According to the Outline of Planning, by 2020 the total output value of the Pharmaceutical Industry will account for more than 30% of the total output value of the pharmaceutical industry, and the Chinese medicine industry will become one of the important pillars of the national economy.
industry forecasts, "13th Five-Year Plan" period, the pharmaceutical economy from the previous super-high-speed growth to medium-high-speed growth is still available; Supply and demand and policies work together, the Chinese medicine industry ushered in a double good. At present, there are about 1200 kinds of Chinese herbal medicine, the annual production of Chinese herbal medicine planted in the country is about 3 million tons, the demand is expected to reach 6.7 million tons by 2020.
prospects of the Chinese medicine industry can not hide the current difficulties faced by the Chinese medicine industry: the concentration of the Chinese medicine industry is low, the destruction of wild Chinese herbal medicine resources is serious, the quality of some Chinese herbal medicines has declined, affecting the sustainable development of Chinese medicine.
2016 China's Chinese herbal medicine cultivation enterprises and Chinese medicine production enterprises strategy summit, from all over the country, Chinese medicine industry enterprises to improve the quality of Chinese herbal medicine has been discussed in depth. Zhao Haiying, chairman of Fujian Hai Pharmaceutical Co., Ltd., said that a large area of the country carried out a large area of Chinese herbal medicine introduction and success, but there are also many varieties gradually lost the advantage of origin, blind introduction of varieties is currently the cause of the important reason for the failure of medicinal herbs.
" at present, there is blindness in the cultivation of Chinese herbal medicines, planting without considering suitable areas, only considering prices. Relevant government departments should give scientific guidance, help to do a good job in the selection of varieties of research and technical training, and take advantage of the advantages of mastering the national information, the release of information on Chinese medicine, to avoid blind introduction of species. Zhao Haiying said.
Other links in the production and processing of Chinese herbal medicine also have many hidden dangers: such as backward processing methods, the use of road sun exposure, sulfur fumigation and other ways;
, executive director of Yunnan White Pharmaceutical Group Chinese Medicine Resources Co., Ltd., believes that the initial processing method is an important link to ensure the effective content of medicinal herbs to be dissected and not lost. At present, most of the harvesting and processing of traditional Chinese herbal medicines still follow the traditional methods, and most of them are scattered in the pharmaceutical farmers a family, it is difficult to ensure the stability and unity of quality. The base of medicinal herbs shall establish a standardized primary processing plant for Chinese herbal medicines, which can be processed by acquiring fresh herbs for the dispersal of chinese herbal medicines planted. This can not only ensure the quality of Chinese herbal medicine, but also through large-scale processing, standardized graded packaging to improve the added value of medicinal herbs. This should be the development trend of the processing of Chinese herbal medicines.standardization is the direction
" Chinese herbal medicine cultivation base to a new type of higher standards and requirements. Wang Weiquan, chairman of the Chinese Medicine Association's Special Committee on Chinese Medicine Breeding, said that the quality of medicinal herbs should be fundamentally improved, and the planting base must consciously abide by the standards and norms for the cultivation of medicinal herbs, strictly control the quality of cultivation, and strengthen the supervision of government departments, extending the front end of the monitoring to the source of origin.
not only the cultivation of Chinese herbal medicine, the production of Chinese medicine tablets and Chinese medicine is also facing the problem of quality control. Happily, starting in the second half of this year, China's Chinese medicine series standards are expected to be fully upgraded and perfected. Not long ago, the National Development and Reform Commission and the State Administration of Traditional Chinese Medicine jointly organized and implemented, hundreds of pharmaceutical enterprises across the country to participate in the authoritative Chinese medicine research institutes supported by the standardization of Chinese medicine projects have been launched in Beijing.
The key task of the standardization project of Chinese medicine is to focus on the lack of technical specifications and standards for the whole process of cultivation of Chinese medicine, the production of Chinese medicine tablets and the production of Chinese medicine, focusing on the optimization of technical specifications in all aspects of the production of Chinese medicine, the standards of Chinese medicine products and the traceability of Chinese medicine products. Source system construction, improve and revise a number of Chinese medicine production norms and standards, strengthen the supervision, identification and identification methods of Chinese medicine products, systematically build a standardized service support system for Chinese medicine, promote the Chinese medicine industry "to plant good medicine, produce good medicine, make good medicine."
that the National Development and Reform Commission will invest 737 million yuan in chinese medicine standardization projects. According to the project plan, China's 60 varieties of Chinese medicine and 100 kinds of clinically commonly used Chinese medicine tablets are expected to achieve full quality control in 2018.
The relevant person in charge of the State Administration of Traditional Chinese Medicine said that the standardization of Traditional Chinese medicine is a standardized construction project covering technology, management, policies and regulations, an important task for Chinese medicine to inherit innovation, and an important support for the Chinese medicine industry to break through the bottleneck of development and achieve healthy and sustainable development.
" Chinese medicine to the world to face constraints and barriers, international competitiveness needs to be further improved, industry standards should be more in line with the characteristics of Chinese medicine. Wei Victory, a professor at Beijing University of Traditional Chinese Medicine, said one of the main reasons Why Chinese pharmaceutical companies have suffered repeated setbacks in overseas markets is the lack of recognition of quality standards for Chinese medicine.
The relevant person in charge of the State Administration of Traditional Chinese Medicine said that the current quality standards of Chinese medicine are generally determined by reference to the quality standards of Western medicine, this through individual active ingredients to determine the quality of the standard, the quality control effect of Chinese medicine is not good, it is urgent to establish a quality standards system in line with the characteristics of Chinese medicine itself. Especially in the current international market demand for Chinese medicine continues to heat up the background, improve and improve the quality standards of Chinese medicine, is conducive to domestic Chinese medicine to better participate in international competition, access to greater development. the need for innovation in the
cooperation model, many enterprises said that the market cooperation model innovation to promote the quality of Traditional Chinese medicine, is a more sustainable fundamental policy.
" through the leverage of capital to promote the standardization and standardization of the Chinese medicine resources industry, reconstruct the industrial chain business model and distribution of benefits, mobilize and play the professionalism and vitality of various roles, will become the future of the Chinese medicine resources industry innovation and development of the emerging road. Liu Yan, chairman of Tianjin Tiansli Chinese Medicine Resources Technology Development Company, said tiansli is actively promoting the development model of "industry and capital", and has set up Joao Fund and Big Health Industry Fund to inject strong impetus into the rapid development of the pharmaceutical and medical industry. Due to the particularity of the Chinese medicine resources industry, the capital market pays low attention, which slows down the development of the industry. Tian Shili intends to set up a fund for the development of the Chinese medicine resources industry, with the help of capital driving force, to promote the development of the Chinese medicine resources industry, to promote the upstream cultivation, processing, trade and other links of standardization, marketization, to achieve the benign development of the entire industry.
The Chinese Medicine Resources Industry Fund can exert its capital advantages, attract more capital to the Chinese medicine resources industry on the one hand, bind high-quality partners, integrate the resources in the industry, stimulate the initiative and professionalism of all parties, standardize the cultivation and trading links of Chinese medicine resources, promote the reorganization of assets in the industry, and build a standardized and standardized model of the ecological circle of Chinese medicine resources through the fund. At present, Tianshili has cooperated with the governments of Guizhou, Sichuan, Chongqing and Gansu to try to promote the upgrading of the Chinese medicine industry with the help of government-led funds and precise poverty alleviation policies.
can be expected to play the advantages and guidance role of the fund platform, the establishment of "downstream industrial orders , upstream high-quality resources , industry standard certification and financial products and services" of the Chinese herbal medicine trading platform innovation model. Under the market mechanism, integrate and give full play to the advantages of all parties in the industrial chain, discard the traditional Chinese herbal medicine trade ills, good faith management, high quality and good price, reconstruct the chinese herbal medicine trade integrity system.
For example, you can come up with a core variety purchase order, put into the trade platform for centralized procurement, access to high-quality Chinese herbal medicine, but also to establish certification procedures, the establishment of "Chinese herbal medicine quality standards system" "supplier audit standards" "supplier access standards" and a series of norms, to ensure that the certification system is feasible, fair and just, to ensure that suppliers continue to supply high-quality Chinese herbal medicine.
Wang Weiquan believes that a new organizational management model suitable for the development of chinese herbal medicine cultivation bases should be established. In the farmer-oriented cultivation industry, the absorption and integration of the company's advanced management experience and culture, and gradually improve the level of management. On the basis of mobilizing and exerting the enthusiasm of farmers, we can maximize the interests of both sides and many parties. Planting base must increase the docking with the market, make full use of the new business model and Internet means, so that the sales of planting enterprises smoothly.
Liu Feifei, vice president of sunflower pharmaceutical group, said that the initial form of chinese medicine procurement channels is in the rural market, the distribution of medicinal herbs trading, has now developed to the front end of the market procurement of authentic medicinal herbs, the future direction of development is base construction. For example, large pharmaceutical enterprises self-built base, full management, pharmaceutical joint cooperatives to growers process control, to ensure that the quality of Chinese herbal medicines can be controlled, large pharmaceutical enterprises can also be strong joint, jointly build a base to meet the demand for high-quality medicinal materials. (Economic Daily)